La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

ImExHS Crescita futura

Future criteri di controllo 3/6

Si prevede che ImExHS aumenterà i ricavi a una percentuale annua pari a 20.2%.

Informazioni chiave

n/a

Tasso di crescita degli utili

n/a

Tasso di crescita dell'EPS

Healthcare Services crescita degli utili	22.4%
Tasso di crescita dei ricavi	20.2%
Rendimento futuro del capitale proprio	32.4%
Copertura analitica	Low
Ultimo aggiornamento	25 Jul 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks

Jun 27

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

Jan 02

Previsioni di crescita degli utili e dei ricavi

ASX:IME - Stime future degli analisti e dati finanziari passati (AUD Millions )
Data	Ricavi	Guadagni	Flusso di cassa libero	Liquidità dell'operazione	Avg. Numero di analisti
12/31/2026	37	N/A	N/A	8	1
12/31/2025	31	N/A	N/A	5	1
12/31/2024	24	N/A	N/A	5	1
12/31/2023	20	-4	0	3	N/A
9/30/2023	18	-4	0	2	N/A
6/30/2023	17	-4	-1	1	N/A
3/31/2023	17	-3	-3	-1	N/A
12/31/2022	17	-3	-4	-2	N/A
9/30/2022	18	-3	-5	-2	N/A
6/30/2022	18	-4	-5	-3	N/A
3/31/2022	16	-4	-5	-3	N/A
12/31/2021	13	-5	-6	-3	N/A
9/30/2021	13	-4	-5	-2	N/A
6/30/2021	12	-4	-4	-2	N/A
3/31/2021	11	-4	-4	-2	N/A
12/31/2020	11	-4	-4	-1	N/A
9/30/2020	10	-5	-5	-3	N/A
6/30/2020	10	-6	-6	-4	N/A
3/31/2020	9	-6	-6	-4	N/A
12/31/2019	8	-6	-7	-4	N/A
9/30/2019	7	-6	-6	-3	N/A
6/30/2019	7	-7	-5	-3	N/A
3/31/2019	6	-6	-4	-2	N/A
12/31/2018	6	-5	-3	-2	N/A
9/30/2018	5	-3	-3	-1	N/A
6/30/2018	4	-1	-2	-1	N/A
3/31/2018	4	-1	-1	-1	N/A
12/31/2017	4	-1	0	0	N/A
12/31/2016	3	0	N/A	0	N/A
12/31/2015	4	0	N/A	N/A	N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: Dati insufficienti per determinare se la crescita degli utili prevista IME è superiore al tasso di risparmio ( 2.4% ).

Guadagni vs Mercato: Dati insufficienti per determinare se si prevede che gli utili di IME cresceranno più velocemente del mercato Australian

Guadagni ad alta crescita: Dati insufficienti per determinare se si prevede che gli utili di IME cresceranno in modo significativo nei prossimi 3 anni.

Ricavi vs Mercato: Si prevede che il fatturato di IME ( 20.2% all'anno) crescerà più rapidamente del mercato Australian ( 5.4% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di IME ( 20.2% all'anno) crescerà più rapidamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di IME sarà elevato tra 3 anni ( 32.4 %)

ImExHS Crescita futura

Future criteri di controllo 3/6

Informazioni chiave

Aggiornamenti recenti sulla crescita futura

Price target decreased by 18% to AU$1.50

ImExHS Limited Provides Revenue Guidance for the Second Half and Full Year of 2023

Price target decreased by 10% to AU$1.82

Price target decreased to AU$2.03

ImExHS Limited Revises Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Recent updates

ImExHS Limited (ASX:IME) Might Not Be As Mispriced As It Looks

ImExHS Limited, Annual General Meeting, Apr 23, 2024

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.5 million.

Full year 2023 earnings released: AU$0.10 loss per share (vs AU$0.085 loss in FY 2022)

Price target decreased by 18% to AU$1.50

ImExHS Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

Improved Revenues Required Before ImExHS Limited (ASX:IME) Shares Find Their Feet

First half 2023 earnings released: AU$0.055 loss per share (vs AU$0.053 loss in 1H 2022)

ImExHS Limited Provides Revenue Guidance for the Second Half and Full Year of 2023

New minor risk - Financial data availability

New major risk - Revenue and earnings growth

New minor risk - Share price stability

ImExHS Limited (ASX:IME) Screens Well But There Might Be A Catch

Full year 2022 earnings released: AU$0.085 loss per share (vs AU$0.15 loss in FY 2021)

Price target decreased by 10% to AU$1.82

Less than half of directors are independent

Price target decreased to AU$2.03

ImExHS Limited has completed a Follow-on Equity Offering in the amount of AUD 1.975112 million.

First half 2022 earnings released: AU$0.053 loss per share (vs AU$0.092 loss in 1H 2021)

ImExHS Limited to Report First Half, 2022 Results on Aug 30, 2022

ImExHS Limited Revises Earnings Guidance for the Fiscal Year 2022

Consensus forecasts updated

Less than half of directors are independent

Is ImExHS (ASX:IME) Using Too Much Debt?

Full year 2021 earnings: EPS exceeds analyst expectations

ImExHS Limited, Annual General Meeting, May 19, 2022

ImExHS Limited to Report Fiscal Year 2021 Results on Feb 28, 2022

IMEXHS Launches Aquila in the Thai Market

Consensus revenue estimates fall by 11%

ImExHS Limited Provides Consolidated Revenue Guidance for the Fiscal Year 2021

Non-Executive Chairman recently bought AU$64k worth of stock

Independent Non-Executive Director recently bought AU$59k worth of stock

Price target decreased to AU$2.48

Independent Non-Executive Director recently bought AU$99k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.31 loss in FY 2019)

Market Sentiment Around Loss-Making ImExHS Limited (ASX:IME)

Independent Non-Executive Director recently bought AU$173k worth of stock

Full year 2020 earnings released: AU$0.15 loss per share (vs AU$0.32 loss in FY 2019)

ImExHS Limited to Report Fiscal Year 2020 Results on Feb 26, 2021

Did You Miss ImExHS' (ASX:IME) 60% Share Price Gain?

New 90-day high: AU$2.00

Imexhs Limited Announces Executive Changes

Independent Non-Executive Director recently bought AU$58k worth of stock

First half earnings released

ImExHS Limited announced that it expects to receive AUD 0.5 million in funding from Domatorisaro Pty Ltd

Independent Non-Executive Director recently bought AU$51k worth of stock

ImExHS Limited to Report First Half, 2020 Results on Aug 31, 2020

Previsioni di crescita degli utili e dei ricavi

Previsioni di crescita futura degli analisti

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

Scoprire le aziende in crescita